SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-19-006071
Filing Date
2019-07-11
Accepted
2019-07-11 16:01:27
Documents
6
Period of Report
2019-07-10
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K f8-k.htm 8-K 45730
2 EX-16.1 ex-16d1.htm EX-16.1 4906
3 EX-99.2 ex-99d2.htm EX-99.2 11172
4 GRAPHIC ex-16d1g001.jpg GRAPHIC 32912
5 GRAPHIC ex-16d1g002.jpg GRAPHIC 5773
6 GRAPHIC ex-99d2g001.jpg GRAPHIC 1554
  Complete submission text file 0001558370-19-006071.txt   118888
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35182 | Film No.: 19951191
SIC: 2834 Pharmaceutical Preparations